-+ 0.00%
-+ 0.00%
-+ 0.00%

Achieve Life Sciences names Benjamin Halladay CFO, effective Oct. 5

PUBT·10/01/2026 12:32:45
Listen to the news
Achieve Life Sciences names Benjamin Halladay CFO, effective Oct. 5
  • Achieve Life Sciences named Benjamin Halladay chief financial officer, effective Oct. 5, 2026.
  • Halladay previously served as CFO of Esperion Therapeutics from November 2022 to July 2026.
  • His prior experience includes finance roles at Pfizer, working on Lipitor and Chantix, and at National Oilwell Varco.
  • Outgoing CFO Mark Oki will step down effective Oct. 5, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010830PRIMZONEFULLFEED9837644) on October 01, 2026, and is solely responsible for the information contained therein.